SCHEMBL3478437

SCHEMBL3478437

N[C@@H](C(=O)O)c1ccc(O)c(O)c1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 11/20 0.70
KDM4E B2RXH2 10/20 0.70
HSD17B10 Q99714 8/20 0.70
ALDH1A1 P00352 4/20 0.70
HPGD P15428 4/20 0.70
KMT2A Q03164 4/20 0.70
GRM1 Q13255 3/20 0.70
MEN1 O00255 3/20 0.70
CYP2C9 P11712 3/20 0.70
GRM2 Q14416 2/20 0.70
CYP2C19 P33261 2/20 0.70
BLM P54132 4/20 0.65
LMNA P02545 4/20 0.65
PTGS1 P23219 2/20 0.65
NR1I2 O75469 1/20 0.65
ADRA1A P35348 1/20 0.65
SLC6A2 P23975 2/20 0.58
DRD3 P35462 2/20 0.58
CYP2D6 P10635 1/20 0.58
GRM8 O00222 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10723439 1.00 TDP1 (0.70) TDP1KDM4EHSD17B10ALDH1A1HPGD
SCHEMBL449665 1.00 TDP1 (0.70) TDP1KDM4EHSD17B10ALDH1A1HPGD
Bromide SCHEMBL11670638 0.98 TDP1 (0.68) TDP1KDM4EHSD17B10ALDH1A1HPGD
SCHEMBL10721569 0.83 TDP1 (0.55) TDP1KDM4EHSD17B10ALDH1A1HPGD
SCHEMBL11926758 0.83 TDP1 (0.55) TDP1KDM4EHSD17B10ALDH1A1HPGD
SCHEMBL12648648 0.82 HSD17B10 (1.00) TDP1KDM4EHSD17B10ALDH1A1HPGD
SCHEMBL20522819 0.82 HSD17B10 (0.64) TDP1KDM4EHSD17B10ALDH1A1HPGD
SCHEMBL20693801 0.82 HSD17B10 (0.64) TDP1KDM4EHSD17B10ALDH1A1HPGD
SCHEMBL20522818 0.82 HSD17B10 (0.64) TDP1KDM4EHSD17B10ALDH1A1HPGD
SCHEMBL11396129 0.82 HSD17B10 (0.64) TDP1KDM4EHSD17B10ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11759435-B2 Dihydrochalcone derivatives influencing inflammatory states SYMRISE AG (DE) 2023-09-19 US disclosed
US-20220226261-A1 DIHYDROCHALCONE DERIVATIVES INFLUENCING INFLAMMATORY STATES SYMRISE AG (DE) 2022-07-21 US disclosed
CN-109310649-B Dihydrochalcone derivatives affecting inflammatory states 西姆莱斯有限公司 2021-06-29 CN disclosed
US-10758468-B2 Solubilizer for cosmetic preparations SYMRISE AG (DE) 2020-09-01 US disclosed
EP-2633886-B1 COMPOUNDS AND MIXTURES INFLUENCING INFLAMMATORY STATES SYMRISE AG (DE) 2018-01-31 EP disclosed
WO-2017186298-A1 DIHYDROCHALCONE DERIVATIVES INFLUENCING INFLAMMATORY STATES SYMRISE AG (DE) 2017-11-02 WO disclosed
US-20160106650-A1 SOLUBILIZER FOR COSMETIC PREPARATIONS SYMRISE AG (DE) 2016-04-21 US disclosed
US-8961943-B2 O/W-emulsifiers, O/W-emulsions and methods of manufacture thereof SYMRISE AG (DE) 2015-02-24 US disclosed
US-8906958-B2 Compounds and mixtures for influencing inflammatory states SYMRISE AG (DE) 2014-12-09 US disclosed
US-20130251730-A1 Compounds and Mixtures Influencing Inflammatory States SYMRISE AG (DE) 2013-09-26 US disclosed
US-20130177510-A1 O/W-EMULSIFIERS, O/W-EMULSIONS AND METHODS OF MANUFACTURE THEREOF SYMRISE AG (DE) 2013-07-11 US disclosed
US-8454941-B2 O/W-emulsifiers, O/W-emulsions and methods of manufacture thereof SYMRISE AG (DE) 2013-06-04 US disclosed
US-20120129937-A1 SOLUBILIZER FOR COSMETIC PREPARATIONS SYMRISE AG (DE) 2012-05-24 US disclosed
US-20100284948-A1 O/W-EMULSIFIERS, O/W-EMULSIONS AND METHODS OF MANUFACTURE THEREOF SYMRISE AG (DE) 2010-11-11 US disclosed
US-7731982-B2 O/W emulsifier, O/W emulsion and applications thereof SYMRISE GMBH & CO. KG (US) 2010-06-08 US disclosed
US-20060165738-A1 O/w emulsifier, o/w emulsion and applications thereof SYMRISE AG (DE) 2006-07-27 US disclosed
US-20030171617-A1 3,4-Dihydroxymandelic acid alkylamides and use thereof HAARMANN & REIMER GMBH (DE) 2003-09-11 US disclosed
US-20030139470-A1 3,4-dihydroxybenzyl-substituted carbonic acid derivatives and the use thereof as antioxidants HAARMANN & REIMER GMBH (DE) 2003-07-24 US disclosed
US-20030072725-A1 Topical cosmetic agents containing 2-hydrazino-1,3 -heteroazoles HAARMANN & REIMER GMBH (DE) 2003-04-17 US disclosed
US-20030049287-A1 Catechol oximes and their use in cosmetic and dermatological preparations HAARMANN & REIMER GMBH (DE) 2003-03-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130251730-A1 Compounds and Mixtures Influencing Inflammatory States MSR1, MPO, IL1B TDP1 3550/4885KDM4E 2721/4885HSD17B10 1122/4885
US-10758468-B2 Solubilizer for cosmetic preparations SRPK3, SRPK1, SYMPK TDP1 2561/4885KDM4E 1107/4885HSD17B10 650/4885
US-20030171617-A1 3,4-Dihydroxymandelic acid alkylamides and use thereof HNMT, HTR2A, HTR2C TDP1 1702/4885KDM4E 1863/4885HSD17B10 663/4885
US-20030049287-A1 Catechol oximes and their use in cosmetic and dermatological preparations TYR, LPO, COMT TDP1 989/4885KDM4E 543/4885HSD17B10 447/4885
US-20120129937-A1 SOLUBILIZER FOR COSMETIC PREPARATIONS SRPK3, SRPK1, SYMPK TDP1 2561/4885KDM4E 1107/4885HSD17B10 650/4885
US-20030139470-A1 3,4-dihydroxybenzyl-substituted carbonic acid derivatives and the use thereof as antioxidants TYR, HAAO, TH TDP1 745/4885KDM4E 186/4885HSD17B10 284/4885
US-11759435-B2 Dihydrochalcone derivatives influencing inflammatory states IL17A, TNF, IL1B TDP1 3846/4885KDM4E 2237/4885HSD17B10 37/4885
US-20030072725-A1 Topical cosmetic agents containing 2-hydrazino-1,3 -heteroazoles TYR, MITF, HDAC1 TDP1 508/4885KDM4E 2169/4885HSD17B10 302/4885
US-20160106650-A1 SOLUBILIZER FOR COSMETIC PREPARATIONS SRPK3, SRPK1, SYMPK TDP1 2561/4885KDM4E 1107/4885HSD17B10 650/4885
US-20220226261-A1 DIHYDROCHALCONE DERIVATIVES INFLUENCING INFLAMMATORY STATES IL17A, TNF, IL1B TDP1 3846/4885KDM4E 2237/4885HSD17B10 37/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.